Table 2. Outcome of minor... | American Society of Hematology

Table 2.

Outcome of minor histocompatibility antigen-sensitized DLI (mHA-DLI) in mixed chimeric recipients

Dog	Conditioning (Gy)	% Donor chimerism before mHA-DLI		Day of mHA-DLI^†	CD3⁺ cells infused (×10⁷/kg)	% Donor chimerism after mHA-DLI^*
Dog	Conditioning (Gy)	PBMC	PBG	Day of mHA-DLI^†	CD3⁺ cells infused (×10⁷/kg)	PBMC	PBG
E272	1 TBI	40	30	651	12.0	100	100
E360^‡	2 TBI	52	64	378	5.1	100	100
E367	1 TBI	60	90	490	2.4	100	100
E390^‡	2 TBI	80	82	414	7.1	100	100
E399^2-153	4.5 LNI	5	5	389	6.1	100	100
E400	4.5 LNI	64	65	503	15.0	100	100
E433	2 TBI	70	82	420	8.5	98	98
E501	2 TBI	50	54	201	5.8	100	100

Dog	Conditioning (Gy)	% Donor chimerism before mHA-DLI		Day of mHA-DLI^†	CD3⁺ cells infused (×10⁷/kg)	% Donor chimerism after mHA-DLI^*
Dog	Conditioning (Gy)	PBMC	PBG	Day of mHA-DLI^†	CD3⁺ cells infused (×10⁷/kg)	PBMC	PBG
E272	1 TBI	40	30	651	12.0	100	100
E360^‡	2 TBI	52	64	378	5.1	100	100
E367	1 TBI	60	90	490	2.4	100	100
E390^‡	2 TBI	80	82	414	7.1	100	100
E399^2-153	4.5 LNI	5	5	389	6.1	100	100
E400	4.5 LNI	64	65	503	15.0	100	100
E433	2 TBI	70	82	420	8.5	98	98
E501	2 TBI	50	54	201	5.8	100	100

Determined 8 to 12 weeks after mHA-DLI.

Day after transplantation.

Graft-versus-host disease developed in dogs E360 and E390.

Marrow aplasia developed in dog E399.